Bal Pharma Ltd.

BSE: 524824 | NSE: BALPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE083D01012 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Bal Pharma Ltd Bal Pharma Ltd. | BSE 73.59 0.34 (0.46%) | NSE 73.02 -0.30 (-0.41%) | Trade | Add

BSE Live

Jan 01, 16:01

73.59 0.34 (0.46%)

Volume

AVERAGE VOLUME

5-Day

4,268

10-Day

2,306

30-Day

1,771

Prev. Close

73.25
Open Price

72.11

Bid Price (Qty.)
72.30 (1)
Offer Price (Qty.)
76.49 (50)

NSE Live

Jan 01, 15:41

73.02 -0.30 (-0.41%)

Volume

AVERAGE VOLUME

5-Day

8,619

10-Day

6,517

30-Day

7,954

2,557

Prev. Close

73.32
Open Price

71.50

Bid Price (Qty.)
73.02 (10)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Bal Pharma (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	14.17	14.17	14.17	14.17	12.87
Total Share Capital	14.17	14.17	14.17	14.17	12.87
Reserves and Surplus	38.25	52.47	50.82	48.27	40.01
Total Reserves and Surplus	38.25	52.47	50.82	48.27	40.01
Total Shareholders Funds	52.43	66.64	64.99	62.45	54.90
Minority Interest	-7.09	-6.42	-4.79	-2.38	-0.18
NON-CURRENT LIABILITIES
Long Term Borrowings	23.15	28.76	34.68	17.80	34.96
Deferred Tax Liabilities [Net]	3.58	4.18	7.57	7.75	6.98
Other Long Term Liabilities	3.21	2.20	1.28	1.05	0.90
Long Term Provisions	3.62	2.71	2.05	3.42	2.28
Total Non-Current Liabilities	33.56	37.85	45.57	30.02	45.12
CURRENT LIABILITIES
Short Term Borrowings	89.63	87.08	68.31	71.07	50.09
Trade Payables	38.67	47.34	49.96	54.43	46.85
Other Current Liabilities	30.69	28.32	35.76	17.55	12.01
Short Term Provisions	0.50	0.51	0.38	0.19	2.24
Total Current Liabilities	159.49	163.24	154.41	143.24	111.19
Total Capital And Liabilities	238.39	261.31	260.18	233.33	211.03
ASSETS
NON-CURRENT ASSETS
Tangible Assets	60.45	60.85	63.16	55.31	51.60
Intangible Assets	6.43	5.71	4.49	4.67	4.63
Capital Work-In-Progress	3.32	3.63	0.21	1.70	3.93
Fixed Assets	70.20	70.19	67.86	61.69	60.16
Non-Current Investments	0.00	0.02	0.02	0.02	0.02
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	0.29	1.86	2.40	2.12	7.54
Other Non-Current Assets	2.94	3.51	1.31	4.95	0.32
Total Non-Current Assets	77.26	79.40	75.41	68.78	68.03
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	67.71	69.75	66.49	54.73	41.75
Trade Receivables	49.60	64.69	64.05	61.80	56.94
Cash And Cash Equivalents	3.13	4.32	4.15	4.71	4.63
Short Term Loans And Advances	2.21	2.16	2.05	0.64	39.60
OtherCurrentAssets	38.48	40.98	48.03	42.67	0.07
Total Current Assets	161.14	181.91	184.77	164.55	143.00
Total Assets	238.39	261.31	260.18	233.33	211.03
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	12.99	20.37	8.93	12.91	20.49
BONUS DETAILS
Bonus Equity Share Capital	3.04	3.04	3.04	3.04	3.04
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.11	0.11	0.00	0.00
Non-Current Investments Unquoted Book Value	0.00	0.02	0.02	0.02	0.02
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00